Journal article
Blood-based proteomic biomarkers of Alzheimer’s disease pathology
- Abstract:
-
The complexity of Alzheimer’s disease (AD) and its long prodromal phase poses challenges for early diagnosis and yet allows for the possibility of the development of disease modifying treatments for secondary prevention. It is, therefore, of importance to develop biomarkers, in particular, in the preclinical or early phases that reflect the pathological characteristics of the disease and, moreover, could be of utility in triaging subjects for preventative therapeutic clinical trials. Much res...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Bibliographic Details
- Publisher:
- Frontiers Publisher's website
- Journal:
- Frontiers in Neurology Journal website
- Volume:
- 6
- Article number:
- 6:236
- Publication date:
- 2015-11-16
- DOI:
- EISSN:
-
1664-2295
Item Description
- Keywords:
- Pubs id:
-
pubs:578275
- UUID:
-
uuid:88fc6c6a-9863-4df8-b371-c669a471e41c
- Local pid:
- pubs:578275
- Source identifiers:
-
578275
- Deposit date:
- 2015-12-09
Terms of use
- Copyright holder:
- Baird et al
- Copyright date:
- 2015
- Notes:
- This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
- Licence:
- CC Attribution (CC BY)
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record